Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

990results about How to "Extended maintenance period" patented technology

Solid organometallic compound-filled container and filling method thereof

A novel filled container is provided, which can stably supply an apparatus for vapor phase epitaxial growth such as an MOCVD apparatus with a solid organometallic compound over a long term. The solid organometallic compound-filled container has a carrier gas inlet and a carrier gas outlet. The interior of the filled container is separated into a plurality of vertical compartments. A carrier gas introduced via the carrier gas inlet flows through each of the vertical compartments and is then discharged via the carrier gas outlet.
Owner:TOSOH FINECHEM CORP

Production of proteins by cell culture

Methods for obtaining a protein by culture of hybridoma cells, wherein said protein is an immunoglobulin, are disclosed. The methods involve culturing animal hybridoma cells in continuous presence of an alkanoic acid or salt thereof, which enhances protein production, wherein said alkanoic acid or salt thereof is present at 2 concentration range of 0.1 mM to 200 mM.
Owner:LONZA LTD

Methods, products, systems, and devices for processing reusable information

InactiveUS20080010365A1Increase subscription periodMinimize useData processing applicationsDigital computer detailsClient-sideTelecommunications link
In a communication network having at least one communication link connecting at least one provider and a client, where the at least one provider is in communication with at least one database storing at least one identifier having variable ownership status, a method includes establishing that at least one identifier of significance to the client is unavailable for ownership by the client, communicating to the at least one provider at least one desired action the at least one provider is to take on behalf of the client to obtain an ownership interest in the at least one identifier of significance to the client, where the at least one identifier of significance to the client is unavailable for ownership by the client at the time of the communication, and determining whether to perform the at least one desired action without monitoring the ownership status of the at least one identifier of significance to the client.
Owner:MEC MANAGEMENT LLC +1

Liquid crystal display

A liquid crystal display of the invention includes a plurality of pixels each of which has a liquid crystal layer and a plurality of electrodes for applying a voltage to the liquid crystal layer and which are arranged in a matrix of rows and columns, wherein: each of the plurality of pixels has a first sub-pixel and a second sub-pixel which can apply mutually different voltages to the liquid crystal layer, where the first sub-pixel has a higher brightness than the second sub-pixel in certain gradations; the first sub-pixel and the second sub-pixel each has: a liquid crystal capacitor formed by a counter electrode and a sub-pixel electrode opposing the counter electrode via the liquid crystal layer, and a storage capacitor formed by a storage capacitor electrode connected electrically to the sub-pixel electrode, an insulating layer, and a storage capacitor counter electrode opposing the storage capacitor electrode via the insulating layer; the counter electrode is a single electrode shared by the first sub-pixel and the second sub-pixel, and the storage capacitor counter electrodes of the first sub-pixel and the second sub-pixel are electrically independent of each other; and the storage capacitor counter electrode of the first sub-pixel in any of the plurality of pixels and the storage capacitor counter electrode of the second sub-pixel of a pixel adjacent to any of the pixels in the column direction are electrically independent of each other.
Owner:SHARP KK

Self contained ambulatory blood pressure cincture

A long term ambulatory blood pressure monitor is disclosed in which all elements of the monitor are compactly and inconspicuously contained in / on a cincture housing mounted on an inflatable arm band fixedly and comfortably positioned on the patient arm. System control and display modules are efficiently placed in a flip top mode on the cincture housing itself and alternatively in a wrist watch mode on the patient wrist. Non volatile EEPROM blood pressure data memory is disposed adjacent EPROM system memory and microprocessor controller circuitry on a compact PCB within the cincture housing along with pneumatic motor / pump and solenoid for inflation / deflation of the arm band to obtain systolic / diastolic blood pressure readings via the oscillatory detection method.
Owner:SPACELABS HEALTHCARE LLC

Barriers for polymer-coated implantable medical devices and methods for making the same

InactiveUS6953560B1Reduce and prevent and inflammationReduce and prevent proliferationStentsSurgeryHafniumPt element
An implantable medical device and methods for making the implantable medical device are disclosed. The implantable medical device includes a substrate. At least a portion of the substrate is coated with a first layer including a polymer containing a drug. A barrier overlies the first layer. The barrier significantly reduces the rate of release of the drug from the polymer, thereby sustaining release of the drug from the medical device for a longer time.The barrier may be a homogeneous layer overlying the first layer, or a number of discrete deposits over the first layer. Alternatively, the barrier may be intermixed with an outer portion of the first layer. The barrier material is biocompatible, and typically has a thickness ranging from about 50 angstroms to about 20,000 microns. Suitable materials for the barrier include, but are not limited to, inorganic compounds, such as inorganic silicides, oxides, nitrides, carbides, as well as pure metals such as aluminum, chromium, gold, hafnium, iridium, niobium, palladium, platinum, tantalum, titanium, tungsten, zirconium, and alloys of these metals. The barriers disclosed may be applied to the first layer by several techniques, depending on the material being applied. Exemplary deposition techniques include physical vapor deposition, alkoxide hydrolysis, and electroless plating.The implantable device may be a stent or a graft, among other possibilities.
Owner:ABBOTT CARDIOVASCULAR

Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles

Apparatus and methods are provided for interacting light with particles, including but not limited to biological matter such as cells, in unique and highly useful ways. Optophoresis consists of subjecting particles to various optical forces, especially optical gradient forces, and more particularly moving optical gradient forces, so as to obtain useful results. In biology, this technology represents a practical approach to probing the inner workings of a living cell, preferably without any dyes, labels or other markers. In one aspect, a particle may be characterized by determining its optophoretic constant or signature. For example, a diseased cell has a different optophoretic constant from a healthy cell, thereby providing information, or the basis for sorting. In the event of physical sorting, various forces may be used for separation, including fluidic forces, such as through the use of laminar flow, or optical forces, or mechanical forces, such as through adhesion. Various techniques for measuring the dielectric constant of particles are provided.
Owner:WANG MARK M +8

Implantable RF telemetry devices with power saving mode

An electronic implantable device with a power saving circuit incorporates a radio frequency receiver with low power consumption. A high power radio receiver is normally turned off during a period of inactivity. When an analyzer detects a predetermined identification code in a received radio frequency signal, it outputs a signal to turn on the high power receiver.
Owner:MICROSEMI SEMICON

System and method for reliably communicating the content of a live data stream

A method for communicating the content of a live data stream to a receiver using a plurality of channels comprising two encoder channels used to encode the live data content prior to transmission. Initially a plurality of segments of a live data stream are received, wherein each segment contains segment data. A forward error correction algorithm is applied to each segment's data, thereby producing FEC-encoded segment data. The FEC-encoded segment data is contained within an FEC-encoded block, resulting in a corresponding plurality of FEC-encoded blocks being generated. Each FEC-encoded block is copied to a sub-channel on both a first encoder channel and a second encoder channel, resulting in a plurality of FEC-encoder blocks residing on the first and second encoder channels. The first and second encoder channels differ in the number of sub-channels they contain (interleaving depth), and accordingly the arrangement of the FEC-encoded blocks in the first and second encoder channels are different. A first cross-section of the FEC-encoded segment data contained within the FEC-encoded blocks resident in the first encoder channel is added to a first transmit block T0. Similarly, A first cross-section of the FEC-encoded segment data contained within the FEC-encoded blocks resident in the second encoder channel is added to a second transmit block T1. The first and second transmit blocks are then communicated to the receiver.
Owner:QUALCOMM INC

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

Controlled release oral dosage forms are provided for the continuous, sustained administration of a pharmacologically active agent to the upper gastrointestinal tract of a patient in whom the fed mode as been induced. The majority of the agent is delivered, on an extended release basis, to the stomach, duodenum and upper regions of the small intestine, with drug delivery in the lower gastrointestinal tract and colon substantially restricted. The dosage form comprises a matrix of a biocompatible, hydrophilic, erodible polymer with an active agent incorporated therein, wherein the polymer is one that both swells in the presence of water and gradually erodes over a time period of hours, with swelling and erosion commencing upon contact with gastric fluid, and drug release rate primarily controlled by erosion rate.
Owner:DEPOMED SYST INC

Power generation assemblies, and apparatus for use therewith

A floating power generation assembly comprises at least three floating units (900) floating on a body of water, and at least three anchors (916) secured to a solid surface beneath the body of water, each of the floating units (900) being provided with power generation means, the floating units (900) being arranged substantially at the vertices of at least one equilateral triangle. The invention also provides ship-borne apparatus for deploying the floating units of such a power generation assembly and a novel multiple wind turbine assembly.
Owner:OCEAN WIND TECH

Barriers for polymer-coated implantable medical devices and methods for making the same

InactiveUS20050208098A1Reduce and prevent and inflammationReduce and prevent proliferationStentsSurgeryBiomedical engineeringMedical treatment
A drug eluting medical device is disclosed. The device includes a barrier layer for reducing the rate of release of a drug.
Owner:ABBOTT CARDIOVASCULAR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products